- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x WTD: 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide(Non-covalent)
WTD.3: 13 residues within 4Å:- Chain A: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.1, MN.2
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.44, A:K.54
- Hydrogen bonds: A:K.54, A:Y.131, A:K.135
- pi-Stacking: A:Y.44
WTD.10: 13 residues within 4Å:- Chain B: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.8, MN.9
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:Y.44, B:K.54
- Hydrogen bonds: B:K.54, B:Y.131, B:K.135
- pi-Stacking: B:Y.44
WTD.17: 13 residues within 4Å:- Chain C: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.15, MN.16
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:Y.44, C:K.54
- Hydrogen bonds: C:K.54, C:Y.131, C:K.135
- pi-Stacking: C:Y.44
WTD.24: 13 residues within 4Å:- Chain D: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.22, MN.23
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:Y.44, D:K.54
- Hydrogen bonds: D:K.54, D:Y.131, D:K.135
- pi-Stacking: D:Y.44
WTD.31: 13 residues within 4Å:- Chain E: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.29, MN.30
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:Y.44, E:K.54
- Hydrogen bonds: E:K.54, E:K.135
- pi-Stacking: E:Y.44
WTD.38: 13 residues within 4Å:- Chain F: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.36, MN.37
5 PLIP interactions:5 interactions with chain F- Hydrophobic interactions: F:Y.44, F:K.54
- Hydrogen bonds: F:K.54, F:K.135
- pi-Stacking: F:Y.44
WTD.45: 13 residues within 4Å:- Chain G: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.43, MN.44
5 PLIP interactions:5 interactions with chain G- Hydrophobic interactions: G:Y.44, G:K.54
- Hydrogen bonds: G:K.54, G:K.135
- pi-Stacking: G:Y.44
WTD.52: 13 residues within 4Å:- Chain H: A.40, Y.44, E.46, K.54, H.61, E.81, D.109, E.120, I.121, Y.131, K.135
- Ligands: MN.50, MN.51
7 PLIP interactions:7 interactions with chain H- Hydrophobic interactions: H:Y.44, H:K.54
- Hydrogen bonds: H:K.54, H:E.81, H:K.135
- Water bridges: H:D.109
- pi-Stacking: H:Y.44
- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
QQ4.4: 6 residues within 4Å:- Chain A: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.30
QQ4.11: 6 residues within 4Å:- Chain B: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.30
QQ4.18: 6 residues within 4Å:- Chain C: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.30
QQ4.25: 6 residues within 4Å:- Chain D: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.30
QQ4.32: 6 residues within 4Å:- Chain E: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.30
QQ4.39: 6 residues within 4Å:- Chain F: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.30
QQ4.46: 6 residues within 4Å:- Chain G: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:N.30
QQ4.53: 6 residues within 4Å:- Chain H: N.30, M.32, F.66, I.79, E.81, G.82
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:N.30
- 24 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 2 residues within 4Å:- Chain F: G.18, K.49
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain E: G.18, K.49
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.14: 6 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.19: 2 residues within 4Å:- Chain G: G.18, K.49
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain C: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.26: 2 residues within 4Å:- Chain H: G.18, K.49
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain D: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.28: 6 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.33: 2 residues within 4Å:- Chain B: G.18, K.49
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain E: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.35: 6 residues within 4Å:- Chain E: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain A: G.18, K.49
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain F: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.42: 6 residues within 4Å:- Chain F: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.47: 2 residues within 4Å:- Chain C: G.18, K.49
Ligand excluded by PLIPSO4.48: 4 residues within 4Å:- Chain G: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.49: 6 residues within 4Å:- Chain G: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.54: 2 residues within 4Å:- Chain D: G.18, K.49
Ligand excluded by PLIPSO4.55: 4 residues within 4Å:- Chain H: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.56: 6 residues within 4Å:- Chain H: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cuypers, M.G. et al., The crystal structure of the I38T mutant PA endonuclease (2009/H1N1/California) in complex with SJ000988558. To Be Published
- Release Date
- 2021-11-10
- Peptides
- Protein PA-X: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x WTD: 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide(Non-covalent)
- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
- 24 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cuypers, M.G. et al., The crystal structure of the I38T mutant PA endonuclease (2009/H1N1/California) in complex with SJ000988558. To Be Published
- Release Date
- 2021-11-10
- Peptides
- Protein PA-X: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A